Andrew Ford
Impact in
- Health top 10%
- Vaccine Coverage and Hesitancy
-
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- IL-33, ST2, and ILC Pathways 3
- Mast cells and histamine 1
-
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Ellen Wright Clayton (4 shared papers)Kathleen Stratton (4 shared papers)Achsah Keegan (5 shared papers)Nancy Noben-Trauth (3 shared papers)Irina Mikhailenko (1 shared paper)Preeta Dasgupta (1 shared paper)Ann E. Kelly-Welch (1 shared paper)Elizabeth Smith (2 shared papers)
- Journals
- The Journal of Immunology (3 papers)Vaccine (2 papers)Allergy (1 paper)ACS Biomaterials Science & Engineering (1 paper)BMC Immunology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Andrew Ford
12 papers receiving 412 citations
Peers
Comparison fields: 5 of 90
- Health 79
- Immunology 145
- Immunology and Allergy 40
- Physiology 108
- Infectious Diseases 75
Countries citing papers authored by Andrew Ford
This map shows the geographic impact of Andrew Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Ford more than expected).
Fields of papers citing papers by Andrew Ford
This network shows the impact of papers produced by Andrew Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Ford. The network helps show where Andrew Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adverse Effects of Vaccines: Evidence and Causality | 2013 | 199 |
| 2 | 2012 | 78 | |
| 3 | 2004 | 55 | |
| 4 | 2011 | 40 | |
| 5 | 2009 | 18 | |
| 6 | COMMITTEE TO REVIEW ADVERSE EFFECTS OF VACCINES | 2011 | 12 |
| 7 | 2015 | 10 | |
| 8 | 2019 | 10 | |
| 9 | Diphtheria Toxoid–, Tetanus Toxoid–, and Acellular Pertussis–Containing Vaccines | 2011 | 3 |
| 10 | 2020 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2009 | 2 | |
| 13 | Hepatitis B Vaccine | 2011 | 1 |
About Andrew Ford
Andrew Ford is a scholar working on Immunology, Infectious Diseases, Health, Physiology and Epidemiology, having authored 13 papers that have together received 433 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Vaccine Coverage and Hesitancy (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Asthma and respiratory diseases (3 papers), Ion Channels and Receptors (1 paper), Mast cells and histamine (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Allergic Rhinitis and Sensitization (1 paper). The work is most often cited by research in Health (79 citations), Immunology (145 citations), Immunology and Allergy (40 citations), Physiology (108 citations) and Infectious Diseases (75 citations). Andrew Ford has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Ellen Wright Clayton, Kathleen Stratton, Achsah Keegan, Nancy Noben-Trauth, Irina Mikhailenko, Preeta Dasgupta, Ann E. Kelly-Welch, Elizabeth Smith, Christian C. Haudenschild and Mark Boothby. Their work appears in journals such as The Journal of Immunology, Vaccine, Allergy, ACS Biomaterials Science & Engineering and BMC Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.